The Statistics and Data Management Core will provide essential support for statistical analysis and data management for the three projects proposed in this application. For the past 25 years, the Biostatistics Unit at the Feinstein Institute for Medical Research has collaborated with investigators at the NSLIJ Health System and other Institutes in Phase 1,11 and 111 trials that are sponsored by NIH or by pharmaceutical companies. Dr. Martin Lesser, the Core Learder and the Director of the Biostatistics Unit, and other Core members have extensive experience in the design, data management, and analysis of clinical research projects/trials. This core consists of two components. The Biostatistics component will support Project teams of all three Projects by providing statistical advice in study design, data analysis and interpretation. Additionally, for the Project 3, the Core will explore new methods of statistical classification for differential diagnosis of patients with parkinsonism. The other component ofthe Core is Data Management, which will have primary responsibility forthe development and maintenance ofthe data management system and procedures for all the projects in this application. Support will be provided in many areas including case report form development, data entry, database programming, database query, data quality assurance, report production, auditing, etc.
This Core will assist the Project team in statistical analysis and data management for the three proposed projects, which aim to improve our understanding on pathophysiology, treatment responses, and differential diagnosis for patients with parkinsonism.
|Tripathi, Madhavi; Tang, Chris C; Feigin, Andrew et al. (2016) Automated Differential Diagnosis of Early Parkinsonism Using Metabolic Brain Networks: A Validation Study. J Nucl Med 57:60-6|
|Vo, An; Sako, Wataru; Fujita, Koji et al. (2016) Parkinson's disease-related network topographies characterized with resting state functional MRI. Hum Brain Mapp :|
|Jourdain, Vincent A; Tang, Chris C; Holtbernd, Florian et al. (2016) Flow-metabolism dissociation in the pathogenesis of levodopa-induced dyskinesia. JCI Insight 1:e86615|
|Davis, Marie Y; Johnson, Catherine O; Leverenz, James B et al. (2016) Association of GBA Mutations and the E326K Polymorphism With Motor and Cognitive Progression in Parkinson Disease. JAMA Neurol 73:1217-1224|
|Lerner, Renata P; Bimpisidis, Zisis; Agorastos, Stergiani et al. (2016) Dissociation of metabolic and hemodynamic levodopa responses in the 6-hydroxydopamine rat model. Neurobiol Dis 96:31-37|
|Leaver, Katherine; Poston, Kathleen L (2015) Do CSF Biomarkers Predict Progression to Cognitive Impairment in Parkinson's disease patients? A Systematic Review. Neuropsychol Rev 25:411-23|
|Spetsieris, Phoebe G; Ko, Ji Hyun; Tang, Chris C et al. (2015) Metabolic resting-state brain networks in health and disease. Proc Natl Acad Sci U S A 112:2563-8|
|Ma, Yilong; Johnston, Tom H; Peng, Shichun et al. (2015) Reproducibility of a Parkinsonism-related metabolic brain network in non-human primates: A descriptive pilot study with FDG PET. Mov Disord 30:1283-8|
|MÃ¼ller-Oehring, Eva M; Sullivan, Edith V; Pfefferbaum, Adolf et al. (2015) Task-rest modulation of basal ganglia connectivity in mild to moderate Parkinson's disease. Brain Imaging Behav 9:619-38|
|Ko, Ji Hyun; Lerner, Renata P; Eidelberg, David (2015) Effects of levodopa on regional cerebral metabolism and blood flow. Mov Disord 30:54-63|
Showing the most recent 10 out of 38 publications